/Investor DB

DCI Partners Co. Ltd. — Full Portfolio

2 tracked investments · listed companies and verified rows first

LUCA Scienceluca-science.comJun 2022

LUCA Science develops mitochondrial therapies that supply functional, storable mitochondria to damaged or dysfunctional cells and tissues to restore cellular energy production, targeting conditions such as ischemia-reperfusion injuries including cerebral and myocardial infarction.

BiotechDeep TechHealthtechLongevity

Co-investorsAsahi Kasei Corporate Venture CapitalFast Track InitiativeRemiges Ventures, Inc.4BIO CapitalAstellas Venture Management LLCAxil Capital

株式会社AIメディカルサービスai-ms.comin𝕏Oct 2019

AI Medical Service Inc. develops AI systems that support image-based diagnosis of endoscopy, primarily for detecting gastrointestinal cancers such as stomach and esophageal cancer.

AI & Machine LearningDigital HealthHealthtechMedical DevicesTokyo, JP

Tomohiro Tada(Representative Director & Chief Medical Officer)inYasushi Takikawa(Representative Director)

Co-investorsGlobis Capital PartnersWiLJapan Post Capital Co. Ltd.SoftBank Vision FundSony Ventures Corporation

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.